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Purpose: This study aimed to evaluate the preventive effects of Camellia sinensis 
var. assamica (CSVA) on diabetic nephropathy in in vitro and in vivo models. Ma-
terials and Methods: MDCK cells were incubated with 1 mM of oxalate with or 
without different concentrations of CSVA, then MTT and malondialdehyde (MDA) 
assays were performed to investigate the preventive effects of CSVA on oxalate-
induced cytotoxicity and oxidative stress. Thirty male db/db mice were divided 
into three groups. Group 1 were fed AIN-93G ad libitum; group 2 were fed AIN-
93G mixed with 10% fermented CSVA ad libitum; group 3 were fed AIN-93G 
mixed with 10% non-fermented CSVA ad libitum. The mice were sacrificed 14 
weeks later, and the serum glucose level, 24-hour urine chemistry, and morpholog-
ical changes in the kidneys were examined. Results: As CSVA concentrations in-
creased, viable MDCK cells increased in concentration. MDA production de-
creased over time in the CSVA treated group. The creatinine clearance of group 3 
was lower than those of groups 1 and 2. The amount of urine microalbumin and 
protein in group 1 were higher than those in groups 2 and 3. Also, more glomeru-
lus basement membrane foot processes were preserved in groups 2 and 3. Conclu-
sion: In conclusion, CSVA has beneficial preventive tendencies towards diabetic 
nephropathy in both in vitro and in vivo models.
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INTRODUCTION
Diabetic nephropathy is a microvascular complication of diabetes mellitus associat-
ed with significant morbidity and mortality.1 Because alterations to glomerular 
structures are irreversible, the primary goal of management for patients with diabet-
ic nephropathy is to prevent disease progression to end stage renal disease. There-
fore, strict control of blood pressure as well as maintaining normal glucose and lipid 
levels are important for preserving renal function.2 However, it is well known that 
attempts to control these factors are not sufficient for the prevention of progression 
of diabetic nephropathy. Thus, many investigators have started to study the effects Effects of Green Tea Extracts on Diabetic Nephropathy
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added, followed by incubation for four hours at 37°C. Optical 
densities were measured on a microplate reader (Becton 
Dickinson Labware, Franklin Lakes, NJ, USA) at 540 nm.
Malondialdehyde (MDA) assay
MDCK cells were exposed to 1 mM of sodium oxalate for 
various periods of time (30, 60, and 120 minutes) with or 
without 50 μg/L of CSVA extract. The lipid peroxidation 
levels were then evaluated by measuring the MDA as de-
scribed by Wong, et al.8  
In vivo study
Animals and group controls
All surgical and experimental procedures were approved by 
the Seoul National University Institutional Animal Care and 
Use Committee (SNUIACUC, No. 08-0213) and conducted 
between November 2008 and February 2009. Thirty male 
C57BL/Ks db/db mice were divided into three groups by ran-
dom sampling methods after adaptation to their new environ-
ment for one week. Group 1 (n=10) were fed AIN-93G ad li-
bitum. Group 2 (n=10) were fed AIN-93G mixed with 10% 
fermented CSVA ad libitum. Group 3 (n=10) were fed AIN-
93G mixed with 10% non-fermented CSVA ad libitum. Table 
1 shows the composition of the basal and experimental diets 
in each group.
Experimental protocols
We monitored the total amounts of food and water intake 
and the body weight of the mice every week. At 6 and 12 
weeks of oral intake, blood was collected from the tail-vein 
and fasting blood glucose levels were measured using Accu-
Chek Performa blood glucose monitoring system (glucome-
ter) (Roche Diagnostics, Pleasanton, CA, USA). After 14 
weeks of the designated oral intake, 24-hour urine was col-
lected from each mouse in their metabolic cages. We evalu-
ated several factors to assess the effects of CSVA on diabetic 
nephropathy. These factors included the results of the 24-
hour urine analysis, which measured creatinine clearance 
(Ccr), amount of microalbumin, and total protein. In addi-
tion, we examined the histology of the kidneys of all experi-
mental mice to determine the effects of CSVA on the mor-
phology of diabetic nephropathy. For these examinations, all 
mice were sacrificed using the cardiac puncture technique 
after fasting for 12 hours. The kidneys were carefully re-
moved after the abdominal cavity was opened. The fatty tis-
sue was gently removed from the renal parenchyma and the 
of traditional medicines, folk remedies, and herbal medicines 
to identify novel agents that might be effective managing dia-
betic complications, especially diabetic nephropathy.3-7
Recently, interest in green tea as a promising agent for the 
prevention or reduction of risk for many human diseases 
has increased worldwide. With regard to preventing diabet-
ic complications, the antioxidant activity of green tea might 
play an important role. In this study, we aimed to evaluate the 
preventive effects of Camellia sinensis var. assamica (CSVA), 
traditionally consumed as a health-promoting beverage in 
Korea, on diabetic nephropathy in both in vitro and in vivo 
models. In addition, we classified CSVA as a fermented or 
non-fermented leaf in the in vivo protocol and evaluated 
whether the preventive effects on diabetic nephropathy dif-
fered according to the degree of fermentation.
MATERIALS AND METHODS
　　　
In vitro study
Preparation of CSVA
Non-fermented CSVA were obtained from CSVA in Gim-
hae, Korea. Twenty grams of CSVA leaves were extracted 
with 400 mL of 100% methanol in a round-bottom flask 
equipped with a condenser. The temperature of extraction 
was kept at boiling temperature and the extraction mixture 
was constantly stirred with a magnetic bar. After two hours 
of extraction, the extraction mixture was cooled, the vacu-
um filtered (0.45 μm), and the methanol evaporated under 
the vacuum at 40°C.
Cell culture
MDCK cells (American Type Culture Collection, Washington 
D.C, USA) were cultured in a Dulbecco’s modified Eagle 
medium (Invitrogen, Carlsbad, CA, USA) supplemented with 
10% fetal bovine serum (Sigma-Aldrich, St. Louis, MO, 
USA) at 37°C, in air containing 5% CO2.
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay
MDCK cells were subcultured in 96-well plates and grown to 
70-80% confluence. The cells were then exposed to 1 mM of 
sodium oxalate (Alfa Aesar, Ward Hill, MA, USA) to induce 
renal cell damage and various concentrations of CSVA extract 
(0, 10, and 25 μg/L) for 24 hours. Subsequently MTT (0.1 
mg, 50 μL of 2 mg/mL) in phosphate-buffered saline was Min-Yong Kang, et al.
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pylene oxide infiltration, epoxy resin was treated for over-
night and embedded with freshly prepared resin. Finally, the 
specimens were polymerized at 60°C for 48 hours. Follow-
ing the E-firm block formation, ultrathin sections (60 nm) 
were obtained and subjected to electron staining, meaning 
double staining with uranyl acetate for 30 min and lead ci-
trate for 10 min; the specimens were then viewed on trans-
mission electron microscopy (JEM-1200EX, JEOL, Tokyo, 
Japan) operating at 120 kV, which was documented by the 
digital imaging. The remnant renal tissues were then placed 
in formalin for paraffin block formation. The paraffin blocks 
were sectioned and then stained with hematoxylin and eosin 
(H&E). The tissues were then carefully examined by Olym-
pus SZX7 stereomicroscope (Olympus, Tokyo, Japan) with 
a plain objective.
Statistical analysis
The Statistical Package for the Social Sciences (SPSS), ver-
sion 11.0 (SPSS Inc., Chicago, IL, USA) was used for the 
statistical analysis. All experimental results were analyzed 
using ANOVA and Dunnett’s test and are reported as mean 
values±standard deviation. p<0.05 was accepted as statisti-
cally significant. 
RESULTS
 
The effect of CSVA extracts on MDCK cell viability 
following exposure to sodium oxalate
The number of viable MDCK cells significantly decreased 
by 40% after exposure to 1 mM of sodium oxalate as com-
pared to the control group (Fig. 1). In contrast, the number 
kidneys were weighed. For the histological examination un-
der an electron microscope, we excised 1×1 mm of cortical 
tissue from each kidney and immediately fixed the samples 
in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer 
at 4°C for 4 hours and wash them twice (each time for 1 
hour) with 0.1 M buffer. Then, we performed secondary fix-
ation in 2% osmium tetroxide in 0.2 M buffer for 1 hour and 
rinsed twice (each time for 5 min) in 0.2 M buffer and multi-
step dehydration in 70%, 90% and 100% ethanol. After pro-
Fig. 1. MDCK cell viability on the concentration of CSVA following exposure 
to sodium oxalate (*p<0.05). MDCK, Madin-Darby canine kidney; CSVA, 
Camellia sinensis var. assamica.
0
20
40
60
80
100
Control 0 µg/L 10 µg/L 25 µg/L
* *
*
C
e
l
l
 
s
u
r
v
i
v
a
l
 
f
r
a
c
t
i
o
n
 
(
%
)
Fig. 2. MDA levels following exposure to sodium oxalate and CSVA accord-
ing to time (*p<0.05 and **p<0.01 ). MDA, malondialdehyde; CSVA, Camellia 
sinensis var. assamica.
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Table 1. Composition of the Basal and Experimental Diets
Ingredients (%) Group 1 Group 2 Group 3
Corn starch 39.8 39.8 39.8
Casein 20.0 17.9 18.1
Dextrinized starch 13.2 13.2 13.3
Sucrose 10.0 10.1   9.8
Alpha-cellulose   5.0   5.1   5.0
Mineral mixture   3.5   3.5   3.5
Vitamin mixture   1.0   1.0   1.0
L-cystine   0.3   0.3   0.3
Choline bitartrate     0.25     0.25     0.25
Tert-butyl hydroquinone         0.0014         0.0014         0.0014
Soybean oil  7.0   6.9   7.1
Fermented CSVA* 0 10.0   0.0
Non-fermented CSVA* 0   0.0 10.0
CSVA, Camellia sinensis var. assamica.
*Freeze-dried.Effects of Green Tea Extracts on Diabetic Nephropathy
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Histopathological assessment  
Fig. 3 shows the mean weight of the kidneys. Groups 2 and 
3 had significantly decreased kidney weights (the sum of 
right and left; 0.45±0.04 g, 0.36±0.03 g, and 0.34±0.03 g in 
groups 1, 2 and 3, respectively, p<0.05). Optic microscopy 
showed no significant differences in the architecture of the 
glomerulus basement membrane (GBM). However, the 
electron microscope showed that more GBM foot process-
es were preserved in groups 2 and 3, and especially group 3 
had a greater number of foot processes than group 2, while 
group 1 had loss of all of GBM foot processes (Fig. 4).
DISCUSSION
Hyperglycemia is strongly associated with diabetic compli-
cations. Effective control of hyperglycemia is an important 
goal of treatment and prevention.9 However, there are few 
effective agents that prevent the development of diabetic 
nephropathy, although strict control of hyperglycemia is 
possible with the use of several diabetic treatments.10,11 Re-
cently, green tea has been the focus of great interest due to 
its beneficial properties for the prevention and treatment of 
human disease. Several epidemiology and experimental 
of MDCK cells increased as the concentration of CSVA in-
creased, as noted by the fraction of viable MDCK cells: 
62.9%, 66.0%, and 75.1% in order (Fig. 1) (p<0.05). 
MDA levels following exposure to sodium oxalate and 
CSVA extracts 
The MDA production increased with time in the sodium 
oxalate-treated group. In contrast, in the group with co-ex-
posure to CSVA extracts, MDA levels decreased with time 
until 60 minutes, then increased slightly after 120 minutes 
(Fig. 2) (p<0.05). 
Changes in mean body weight  
The mean body weights of the three experimental groups 
were 45.7±2.3 g, 42.5±6.4 g, and 36.2±5.5 g, respectively. 
The mean body weight of group 3 was significantly lower 
than the other two groups (p<0.05) (Table 2).
Serum glucose and urine chemistry
After 6 weeks of oral intake, the mean serum glucose level 
of the control group was higher than that of the CSVA-
treated group (528.9±83.5 mg/dL versus 402.0±100.3 mg/
dL, p<0.05) (Table 2). However, after 12 weeks of oral in-
take, there was no statistical difference in the mean serum 
glucose level between the control and CSVA-treated groups 
(457.5±191.5 mg/dL versus 390.8±115.0 mg/dL, p>0.05) 
(Table 2).
The Ccr of group 3 was 2.8±1.6 μL/min; this result indicat-
ed a significant decrease in the Ccr in group 3 compared to 
those in groups 1 and 2 (p<0.05) (Table 2). The amounts of 
microalbumin and protein in the 24-hour urine of group 1 were 
significantly higher than those of groups 2 and 3 (20.8±5.7 μg 
versus 11.6±5.6 μg and 11.5±9.6 μg in the 24-hour microalbu-
min excretion; 73.3±25.2 μg versus 21.4±9.2 μg and 
24.1±14.0 μg in total protein excretion, p<0.05) (Table 2).
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Fig. 3. The mean kidney weights of the db/db mouse (*p<0.05 and **p<0.01 
relative control).
Table 2. The Overall Results of In Vivo Protocol (db/db mouse)
Group 1 Group 2 Group 3
Mean body weight (g) 45.7±2.3 42.5±6.4 36.2±5.5*
Blood gloucose level (mg/dL)
    At 6 wks 528.9±83.5     402.0±100.3**
    At 12 wks   457.5±191.5 390.8±115.0
24 hrs urine analysis
    Ccr (µL/min)   6.4±3.2   6.4±3.4   2.8±1.6*
    Microalbumin (µg) 20.8±5.7   11.6±5.6* 11.5±9.6*
    Total protein excretion (µg)   73.3±25.2   21.4±9.2*   24.1±14.0*
Ccr, creatinine clearance.
*p<0.05 by Kruskal-Wallis test. 
**p<0.05 by Mann-Whitney U test.Min-Yong Kang, et al.
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and atherosclerosis, which have been associated with free-
radical damage.4-6 
We demonstrated that administration of CSVA for 6 weeks 
lowered serum glucose levels, indicating the beneficial ef-
fect of CSVA on glucose tolerance in the early period of in-
take. However, after 12 weeks of feeding, serum glucose 
levels did not statistically differ between the control and the 
CSVA treated groups. This finding might be explained by 
some experiments that showed that insulin resistance im-
proved gradually and developed to control serum glucose 
levels effectively with age in diabetic mice.7,15 
The results of our study showed that there was less uri-
nary protein excretion in the experimental group than in the 
control group. These findings suggest that administration of 
CSVA reduced the amount of proteinuria, which is consis-
tent with the findings of several previous investigations into 
the beneficial effects of green tea on proteinuria.16,17
Unexpectedly, the 24-hour Ccr and the total kidney weight 
were significantly higher in the control group than in the 
CSVA, especially non-fermented, treated groups. However, 
more GBM foot processes were preserved in the CSVA treat-
ed group. This paradoxical finding might be attributed to a 
hyperfiltration phenomenon caused by loss of the GBM. 
Glomerular filtration rate, kidney size, and plasma renal flow 
were found to be supra-normal in young diabetes patients as 
compared to the non-diabetes controls.18 It was hypothesized 
that alterations to glomerular microcirculation would lead to 
single nephron injury; remnant nephrons would compensate 
with increases in pressures and flows; and that a self-perpetu-
ating cycle of renal injury would be established.19 
In addition, we found that non-fermented CSVA was more 
effective with regards to controlling body weight, Ccr, and 
histological changes in diabetic nephropathy than ferment-
ed CSVA. This suggests that fermentation of CSVA might 
attenuate the beneficial effects on body weight control, Ccr 
studies have provided evidence that green tea has antioxi-
dant activity, anticarcinogenic potential, and preventive ef-
fects towards cardiovascular disease.4-7 However, there is 
still controversy regarding the beneficial effects of green tea 
on diabetic nephropathy.
Renno, et al.3 recently showed that green tea had long-
term beneficial effects on diabetic nephropathy in an animal 
model. They reported that green tea catechins improved lev-
els of serum glucose and glycosylated protein as well as the 
urine parameters. Ryu, et al.12 did not find that green tea had 
beneficial effects on serum glucose levels or insulin resis-
tance in their study. However, these conflicting findings 
might be due to differences in doses, amounts of green tea, 
time of exposure and type of green tea as well as the degree 
of hyperglycemia and the methods of experimentation.
There are two basic varieties of green tea; CSVA, a large-
leaf, tall and quick-growing tree well-suited to very warm 
climates, and Camellia sinensis var. sinensis, a small-leaf, 
slower-growing bush that can withstand colder climates. 
Green tea produced from CSVA has been known to have 
higher polyphenol content (30%) than green tea from Ca-
mellia sinensis var. sinensis (20%).13 However, most of 
studies have focused on Camellia sinensis var. sinensis. To 
our knowledge, ours is the first study to show the preven-
tive effect of CSVA on diabetic nephropathy.
We showed that CSVA prevented oxalate-induced cyto-
toxicity and oxidative stress in in vitro experiments. Viable 
MDCK cells proliferated after the administration of CSVA 
extracts, up to about 15%, under conditions of oxalate ex-
posure. In addition, the MDA levels in the CSVA extract-
treated group decreased with time until 60 minutes. Consis-
tent with these results, Jeong, et al.14 reported that green tea 
administration reduced oxalate induced free-radical stress 
in NRK-52E cells. Several studies have reported the anti-
oxidative effects of green tea even in Parkinson’s disease 
Fig. 4. Electron microscopy (EM) of GBM (glomerulus basement membrane): (A) Group 1 is the control group. (B) Group 2 is the fermented 
Camellia sinensis var. assamica (CSVA)-treated group. (C) Group 3 is the non-fermented CSVA-treated group. The black arrows show the 
GBM foot process.
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estry, Ministry for Agriculture, Forestry and Fisheries, Re-
public of Korea.
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